AFT Pharmaceuticals Limited (ASX:AFP)
Australia · Delayed Price · Currency is AUD 2.300
0.00 (0.00%)
Sep 1, 2025, 11:50 AM AEST
AFT Pharmaceuticals Market Cap
AFT Pharmaceuticals has a market cap or net worth of 244.80 million as of September 4, 2025. Its market cap has decreased by -18.94% in one year.
Market Cap
244.80M
Enterprise Value
261.25M
Revenue
189.03M
Ranking
n/a
PE Ratio
22.52
Stock Price
2.30
Market Cap Chart
Since December 22, 2015, AFT Pharmaceuticals's market cap has decreased from 282.68M to 244.80M, a decrease of -13.40%. That is a compound annual growth rate of -1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 244.49M | -11.17% |
| Dec 31, 2024 | 275.23M | -19.28% |
| Dec 29, 2023 | 340.95M | -4.96% |
| Dec 29, 2022 | 358.75M | -18.74% |
| Dec 31, 2021 | 441.47M | -17.88% |
| Dec 31, 2020 | 537.56M | 64.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.05B |
| Pro Medicus | 30.97B |
| Cochlear | 19.36B |
| Sonic Healthcare | 11.37B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.66B |
| Mesoblast | 2.55B |